Get App


Associate Partners

Last Updated : Apr 04, 2019 11:06 AM IST | Source:

Suven Life Sciences gains 4% after securing 4 product patents

The company has been granted one product patent each from Israel, Japan, New Zealand and Sri Lanka.

Moneycontrol News @moneycontrolcom
  • bselive
  • nselive
Todays L/H

Shares of Suven Life Sciences added 4.5 percent intraday Thursday after company secured 4 product patents in Israel, Japan, New Zealand and Sri Lanka.

The company in its press release said that it has been granted one product patent each from Israel, Japan, New Zealand and Sri Lanka corresponding to the new chemical entities for the treatment of disorders associated with Neurodegenerative diseases and patents are valid through 2036 and 2029 respectively.

The granted claims of the patents include the class of selective 5-HT4 and M1 PAM compounds and are being developed as therapeutic agents for neurodegenerative disorders such as for the treatment of cognitive impairment associated with neurodegenerative disorders like Alzheimer’s disease, Attention deficient hyperactivity disorder (ADHD), Huntington’s disease, Pain, Parkinson Disease and Schizophrenia etc.

Venkat Jasti, CEO of Suven said, "We are very pleased by the grant of these patents to Suven for our pipeline of molecules in CNS arena that are being developed for cognitive disorders with high unmet medical need with huge market potential globally."

At 10:58 hrs Suven Life Sciences was quoting at Rs 262.90, up Rs 7.50, or 2.94 percent on the BSE.

For more market news, click here

Get Lok Sabha 2019 Live Election Results, constituency-wise tally, news, views and analysis
Follow our Lok Sabha Election Result Live Blog here.
First Published on Apr 4, 2019 11:06 am
More From
Follow us on
Available On
PCI DSS Compliant